Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1428-1432

  Lin, Patrick P ^a   Brody, Rachel I ^a   Hamelin, Aimée C ^a   Bradner, James E ^a   Healey, John H ^a   Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ARTICLE; BINDING AFFINITY; CHROMOSOME BREAKAGE; CONFORMATIONAL TRANSITION; DNA BINDING; EWING SARCOMA; EXON; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REPORTER GENE; TRANSACTIVATION;

EID: 0033119006     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kovar, H. Progress in the molecular biology of Ewing tumors. Sarcoma, 2: 3-17, 1998.
2. 11 68: and subunits of TFIID and RNA polymerase II complexes. Mol. Cell Biol., 18: 1489-1497, 1998.
3. Petermann, R., Mossier, B., Aryee, D., Khazak, V., Golemis, E., and Kovar, H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene, 17: 603-610, 1998.
4. Remy, P., Senan, F., Meyer, D., Mager, A. M., and Hindelang, C. Overexpression of the xenopus xl-fli gene during early embryogenesis leads to anomalies in head and heart development and erythroid differentiation. Int. J. Dev. Biol., 40: 577-589, 1996.
5. Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., and Thompson, C. B. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem., 269, 18216-18222, 1994.
6. Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., Turc-Carel, C., Ambros, P., Combaret, V., Lenoir, G., Aurias, A., Thomas, G., and Delattre, O. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J., 12: 4481-4487, 1993.
7. Zoubek, A., Dockhom-Dworniczak, B., Delattre, O., Christiansen, H., Niggli, F., Gatterer-Menz, I., Smith, T. L., Jurgens, H., Gadner, H., and Kovar, H. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol., 14: 1245-1251, 1996.
8. de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., Pardo-Mindan, F. J., Ginsberg, J., Womer, R., Lawlor, E. R., Wunder, J., Andrulis, I., Sorensen, P. H. B., Barr, F. G., and Ladanyi, M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. I. Clin. Oncol., 16: 1248-1255, 1998.
9. Zhang, L., Lemarchandel, V., Romeo, P. H., Ben-David, Y., Greer, P., and Bernstein, A. The FLI-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma. encodes a transcriptional activator with DNA-binding specificities distinct from other ETS family members. Oncogene, 8: 1621-1630, 1993.
10. Klemsz, M. J., Maki, R. A., Papayannopoulou, T., Moore, J., and Hromas, R. Characterization of the ETS oncogene family member. FLI-1. J. Biol. Chem., 268: 5769-5773, 1993.
11. Rao, V. N., Ohno, T., Prasad, D. D., Bhattacharya, G., and Reddy, E. S. Analysis of the DNA-binding and transcriptional activation functions of human FLI-1 protein. Oncogene, 8: 2167-2173, 1993.
12. Sharrocks, A. D., Brown, A. L., Ling, Y., and Yates, P. R. The ETS-domain transcription factor family. Int. J. Biochem. Cell Biol., 29: 1371-1387, 1997.
13. Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., and Denny, C. T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ets-family transcription factor. ERG. Nat. Genet., 6: 146-151, 1994.
14. Carrere, S., Verger, A., Flourens, A., Stehelin, D., and Duterque-Coquillaud, M. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene, 16: 3261-3268, 1998.
15. Watson, D. K., Robinson, L., Hodge, D. R., Kola, I., Papas, T. S., and Seth, A. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1A function as ternary and quaternary complex factors on the EGR1 promoter serum response elements. Oncogene, 14: 213-221, 1997.
16. Magnaghi-Jaulin, L., Masutani, H., Robin, P., Lipinski, M., and Harel-Bellan, A. SRE elements are binding sites for the fusion protein EWS-FLI-1. Nucleic Acids Res., 24: 1052-1058, 1996.
17. Ling, Y., West, A. G., Roberts, E. C., Lakey, J. H., and Sharrocks, A. D. Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface J. Biol. Chem., 273: 10506-10514, 1998.
18. Pan, S., Ming, K. Y., Dunn, T. A., Li, K. K., and Lee, K. A. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly. Oncogene, 16: 1625-1631, 1998.
19. Deloulme, J. C., Prichard, L., Delattre, O., and Storm, D. R. The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. J. Biol. Chem., 272: 27369-27377, 1997.
20. Zhang, D., Paley, A. J., and Childs, G. The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J. Biol. Chem., 273: 18086-18091, 1998.
21. Zucman-Rossi, J., Legoix, P., Victor, J. M., Lopez, B., and Thomas, G. Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. USA, 95: 11786-11791, 1998.
22. May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M., and Denny, C. T. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet., 17: 495-497, 1997.
23. Arvand, A., Bastians, H., Welford, S. M., Thompson, A. D., Ruderman, J. V., and Denny, C. T. EWS/FLI1 up-regulales mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene, 17: 2039-2045, 1998.